ADMA - ADMA Biologics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ADMA is currently covered by 4 analysts with an average price target of $26.67. This is a potential upside of $3.71 (16.16%) from yesterday's end of day stock price of $22.96.

ADMA Biologics's activity chart (see below) currently has 25 price targets and 51 ratings on display. The stock rating distribution of ADMA is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 85.71% with an average time for these price targets to be met of 842.71 days.

Highest price target for ADMA is $20, Lowest price target is $14, average price target is $26.67.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 14-Oct-2024. First documented stock forecast 09-Sep-2015.

Currently out of the existing stock ratings of ADMA, 24 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$18

$-1.37 (-7.07%)

$18

25 days ago
(14-Oct-2024)

14/14 (100%)

$1.63 (9.96%)

298

Buy

$20

$0.63 (3.25%)

$20

1 months 19 days ago
(20-Sep-2024)

8/8 (100%)

$0.02 (0.10%)

139

Buy

$14

$-5.37 (-27.72%)

$12

4 months 19 days ago
(20-Jun-2024)

8/8 (100%)

$3.29 (30.72%)

520

Buy

$6

$-13.37 (-69.02%)

1 years 2 months 29 days ago
(10-Aug-2023)

4/4 (100%)

$1.69 (39.21%)

784

Buy

$4

$-15.37 (-79.35%)

$7

4 years 2 days ago
(06-Nov-2020)

6/6 (100%)

$2.09 (109.42%)

1736

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ADMA (ADMA Biologics) average time for price targets to be met?

On average it took 842.71 days on average for the stock forecasts to be realized with a an average price target met ratio 85.71

Which analyst has the current highest performing score on ADMA (ADMA Biologics) with a proven track record?

JASON KOLBERT

Which analyst has the current lower performing score on ADMA (ADMA Biologics) with a proven track record?

JASON MCCARTHY

Which analyst has the most public recommendations on ADMA (ADMA Biologics)?

Jason Kolbert works at BENCHMARK and has 5 price targets and 6 ratings on ADMA

Which analyst is the currently most bullish on ADMA (ADMA Biologics)?

Jason Mccarthy with highest potential upside - $2.33

Which analyst is the currently most reserved on ADMA (ADMA Biologics)?

Leland Gershell with lowest potential downside - -$15.37

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?